5-HTP for Health & Longevity - Quick Reference Sheet

5-HTP for Health & Longevity

Created on 08/07/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4 Audit

5-HTP is a serotonin precursor with medium-strength evidence for short-term appetite and weight support in overweight adults and multi-symptom fibromyalgia relief. Depression, migraine, and sleep evidence is thinner or mixed. Risks are gastrointestinal adverse effects and dangerous combinations with antidepressants or other drugs that raise serotonin. Appears as a situational, time-limited tool for specific targets—not a foundational longevity essential. (Full Review)

Protocol

Common supplemental dose range
50–300 mg/day
Start 50 mg once daily; titrate by 50 mg every several days; many stop at 100–200 mg for sleep/mood
Divided dosing
2–3 split doses
Short half-life (~2–4 h); for sleep, single evening dose 30–60 min before bed is sometimes used
With or without food
With a small snack
Empty stomach may raise absorption but worsen nausea
Time to effect
Appetite / satiety
Within days
Energy intake and short-term weight changes in overweight adults
Fibromyalgia symptoms
2–12 weeks
Multi-symptom relief assessed over trial windows
Sleep quality
Days to weeks
May deepen early sleep then fragment later sleep

Benefits

Contraindications
  • MAOIs (e.g., phenelzine, tranylcypromine, isocarboxazid, selegiline at higher doses; also linezolid)
  • Active serotonin syndrome history
  • Bipolar disorder without psychiatric supervision
  • Pregnancy and lactation
  • Planned urinary 5-HIAA carcinoid testing
  • Children except research or specialist protocols
Key Interactions
  • SSRIs (e.g., sertraline, fluoxetine, escitalopram) and SNRIs (e.g., venlafaxine, duloxetine)
  • Triptans (e.g., sumatriptan, rizatriptan) and other serotonergic migraine drugs
  • Tricyclic antidepressants (e.g., amitriptyline, nortriptyline, imipramine) and other serotonergic psychotropics (e.g., trazodone, mirtazapine)
  • Over-the-counter serotonergic medicines (e.g., dextromethorphan-containing cough/cold products)
  • St. John’s wort, SAMe, L-tryptophan, and multi-ingredient serotonergic mood formulas
  • Carbidopa (specialist-only context)
  • Sedatives / other sleep agents (e.g., zolpidem, eszopiclone, benzodiazepines such as temazepam)

Risk & Side Effects

  • High: Gastrointestinal adverse effects; Serotonin syndrome with serotonergic drugs
  • Medium: Drug and supplement serotonergic interactions; Altered sleep architecture / mid-night awakening
  • Low: Historical contamination / eosinophilia-myalgia syndrome concern; Cardiovascular / autonomic symptoms; Dizziness and lightheadedness; Mania or mood switching; Drowsiness and daytime sedation; Sexual dysfunction / reduced libido; High-dose psychological effects
  • Speculative: Long-term catecholamine imbalance from sustained precursor loading

Monitoring

Marker Target Why
Weight / waist Individual goal trajectory Tracks appetite effect
Sleep metrics Improved continuity & morning restoration Primary endpoint for many users
Mood / anxiety scores Stable or improved vs baseline Detect benefit or activation
Blood pressure / heart rate Stay at personal baseline Autonomic side effects
Comprehensive metabolic panel Within age-adjusted functional targets General safety if high-dose/long-term
CBC with differential Eosinophils within low-normal functional band Historical EMS vigilance
Vitamin B6 (PLP) Plasma PLP in mid-to-upper functional sufficiency range Cofactor for AADC
Urinary 5-HIAA Only if clinically indicated Carcinoid workups (hold 5-HTP before testing)

Cadence: Symptom and side-effect check at 3–7 days, again at 2–4 weeks, then every 4–8 weeks if continued

Qualitative Assessment

  • Sleep continuity and morning restoration (not only total hours)
  • Daytime calm vs. agitation or emotional blunting
  • Appetite: reduced compulsive snacking vs. unpleasant nausea-driven undereating
  • Libido and motivation
  • Training readiness and GI comfort around dosing times